Risa Labs raises $3.5 Mn in seed round led by Binny Bansal

Healthtech startup Risa Labs has raised $3.5 million in a seed funding round led by Flipkart co-founder Binny Bansal. The round also witnessed participation from Oncology Ventures, General Catalyst, z21 Ventures, Odd Bird VC, and angel investor Ashish Gupta.

The proceeds will be used to deploy its AI-based automation platform across 100 cancer centers in the US over the next two years, Risa Labs said in a press release.

Co-founded in 2024 by Kshitij Jaggi and Kumar Shivang, Risa Labs offers a workflow orchestration platform called BOSS (Business Operating System as a Service). The system uses a network of AI agents, including large language models and digital twins, to automate administrative processes by breaking down complex workflows into micro tasks.

Risa Labs weeds out the problems of delaying life-saving treatments due to manual and error-prone workflows. Prior authorisation requirements are a key contributor, with 70% of patients facing delays and a third waiting up to a month — a lag that can increase mortality risk in certain cancer types.

Risa Labs claims that BOSS has already been deployed at a cancer center in the US, where it reduced prior authorisation times from 30 minutes to under five, processed over $1 million in medications, and cut administrative costs by two-thirds.

Risa aims to extend its platform across multiple nodes of the oncology ecosystem, enabling greater coordination and intelligence among providers, life sciences organisations, and other stakeholders as the company aims to build a unified layer for AI-driven orchestration throughout the drug lifecycle.